Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

In Vitro Diagnostics (IVD) market 2020 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Report Description
In vitro diagnostics are diagnostic devices and equipment that extract vital information about an individual or patient after a sequence of tests. Introduction of novel diagnostics test applications on the backdrop of advancements and innovations in the IVD technologies by various organizations has resulted in rampant growth of the in vitro diagnostics (IVD) market, which is expected to sustain in the near future. Diagnoses and tests are precursors to any treatment, which makes in vitro diagnostic market highly lucrative. However, majority of the tests are remotely performed making their presence and use unnoticed. Furthermore, increasing elderly population base and rising demand for diagnostic testing is projected to spur growth of the in vitro diagnostics (IVD) market over the forecast period (2016-2024). Also, growing prevalence of diabetes has increased the demand for in vitro diagnostic tests in the recent past, which is further expected to add on to the sales revenue of the in vitro diagnostic market. In 2014, as per National Diabetes Statistics Report 2014, around 9.3% of the population in the U.S. suffered from diabetes and around 28.0% were undiagnosed.
Market Dynamics
Rapid strides made in technology and inclination of healthcare providers towards expanding their product portfolio is fueling growth of this highly lucrative market, especially in emerging economies, which are largely untapped. Furthermore, rise in prevalence of infectious disease globally, especially in Asia Pacific would inadvertently support market growth in the near future. Major organizations in the in vitro diagnostic market are actively focusing on introducing novel technologies in the testing and diagnostic segments of molecular biology. Such initiatives are projected to bring about a rapid shift in the dynamics of in vitro diagnostics (IVD) market, with Asia Pacific taking on the mantle from North America to emerge as the largest market for in vitro diagnostics, owing to latest technologies and uninterrupted investment in the health care sector is expected further to support the growth in in vitro diagnostic market in the near future.
Market Taxonomy
This report segments the global in vitro diagnostics (IVD) market on the basis of product type, application, end user and geography. On the basis of product, the market is categorized into clinical chemistry, immunoassay, diabetes testing, blood testing, molecular diagnostics and others. On the basis of application the market is divided into infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune disorders and others. On the basis of end user, the market is divided into hospitals, laboratories, homecare diagnostics, research institutes and others. Among all end users, hospitals segment dominated the in vitro diagnostics (IVD) market, owing to rapid advancements in medical systems and developed infrastructure.
Key features of the study:
• This report provides in-depth analysis of the in vitro diagnostics (IVD) market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 - 2024, considering 2015 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global in vitro diagnostics (IVD) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
• Key companies covered as a part of this study Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Sysmex Corporation, Bio-Rad Laboratories, bioMérieux, Becton, Dickinson and Company and Danaher Corporation
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, market expansion, and marketing tactics
• The global in vitro diagnostics (IVD) market report caters to various stakeholders in this industry, including investors, device manufacturers, distributors and suppliers for in vitro diagnostics, research and consulting firms, new entrants, and financial analysts
• Various strategy matrices used in analyzing the in vitro diagnostics (IVD) market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
• Global In Vitro Diagnostics (IVD) Market, By Product Type:
o Clinical Chemistry
o Immunoassay
o Diabetes Testing
o Blood Testing
o Molecular Diagnostics
o Others
• Global In Vitro Diagnostics (IVD) Market, By Application:
o Infectious Diseases
o Diabetes
o Oncology
o Cardiology
o Nephrology
o Autoimmune Disorders
o Others
• Global In Vitro Diagnostics (IVD) Market, By End User:
o Hospitals
o Laboratories
o Homecare Diagnostics
o Research Institutes
o Others
• Global In Vitro Diagnostics (IVD) Market, By Geography:
o North America
 U.S.
 U.S. In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 U.S. In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 U.S. In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Canada
 Canada In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Canada In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Canada In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
o Europe
 U.K.
 U.K In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 U.K In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 U.K In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Germany
 Germany In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Germany In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Germany In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Italy
 Italy In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Italy In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Italy In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 France
 France In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 France In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 France In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Spain
 Spain In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Spain In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Spain In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Russia
 Russia In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Russia In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Russia In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Rest of Europe
 Rest of Europe In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Rest of Europe In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Rest of Europe In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
o Asia-Pacific
 China
 China In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 China In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 China In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 India
 India In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 India In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 India In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Japan
 Japan In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Japan In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Japan In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 ASEAN
 ASEAN In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 ASEAN In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 ASEAN In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Australia
 Australia In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Australia In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Australia In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 South Korea
 South Korea In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 South Korea In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 South Korea In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Rest of Asia Pacific (APAC)
 Rest of Asia Pacific (APAC) In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Rest of Asia Pacific In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Rest of Asia Pacific In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
o Latin America
 Brazil
 Brazil In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Brazil In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Brazil In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Mexico
 Mexico In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Mexico In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Mexico In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Rest of Latin America
 Rest of Latin America In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Rest of Latin America In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Rest of Latin America In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
o Middle East
 GCC
 GCC In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 GCC In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 GCC In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Israel
 Israel In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Israel In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Israel In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Rest of Middle East
 Rest of Middle East In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Rest of Middle East In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Rest of Middle East In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
o Africa
 North Africa
 North Africa In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 North Africa In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 North Africa In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 Central Africa
 Central Africa In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 Central Africa In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 Central Africa In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
 South Africa
 South Africa In Vitro Diagnostics (IVD) Market, By Product Type:
 Clinical Chemistry
 Immunoassay
 Diabetes Testing
 Blood Testing
 Molecular Diagnostics
 Others
 South Africa In Vitro Diagnostics (IVD) Market, By Application:
 Infectious Diseases
 Diabetes
 Oncology
 Cardiology
 Nephrology
 Autoimmune Disorders
 Others
 South Africa In Vitro Diagnostics (IVD) Market, By End User:
 Hospitals
 Laboratories
 Homecare Diagnostics
 Research Institutes
 Others
• Company Profiles
o Roche Diagnostics *
 Company Overview
 Product Portfolio
 Financial Performance
 Key Strategies
 Recent Developments
 Future Plans
o Siemens Healthineers
o C. R. Bard, Inc.
o Abbott Laboratories
o Sysmex Corporation
o Bio-Rad Laboratories
o bioMérieux
o Becton, Dickinson and Company
o Danaher Corporation.
"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Product Type
? Market Snippet By Application
? Market Snippet By End User
? Market Snippet By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Supply Side Drivers
? Demand Side Drivers
? Economic Drivers
? Restraints
? Market Opportunities
o Regulatory Scenario
o Industry Trend
o Merger and Acquisitions
o New Product Approvals/Launch
o Promotion and Marketing Initiatives
4. Global In Vitro Diagnostics Market, By Product Type, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Clinical Chemistry
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Diabetes Testing
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Blood Testing
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Molecular Diagnostics
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Other
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
5. Global In Vitro Diagnostics Market, By Application, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Infectious Diseases
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Diabetes
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Oncology
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Cardiology
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Nephrology
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Autoimmune Disorders
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
6. Global In Vitro Diagnostics Market, By End User, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Hospitals
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Laboratories
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Homecare Diagnostics
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Research Institutes
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
7. Global In Vitro Diagnostics Market, By Regions, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, For Regions, 2014 - 2024
o North America
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.S.
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Canada
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
o Europe
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.K.
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Germany
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Italy
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? France
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Russia
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Rest of Europe
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
o Asia Pacific
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? China
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? India
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Japan
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? ASEAN
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Australia
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? South Korea
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Rest of Asia Pacific
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
o Latin America
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Brazil
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Mexico
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Rest of Latin America
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
o Middle East
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? GCC Countries
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Israel
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Rest of Middle East
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Portability, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
o Africa
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Northern Africa
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? Central Africa
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
? South Africa
? Country Trends
? Market Size and Forecast, By Product Type, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By Application, 2014 - 2024 (US$ Million)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Million)
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profiles
? Roche Diagnostics
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Siemens Healthineers
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? C. R. Bard, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Abbott Laboratories
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Sysmex Corporation
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Bio-Rad Laboratories
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? bioMérieux
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Becton, Dickinson and Company
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Danaher Corporation
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 42 market data tables and 95 figures on "In Vitro Diagnostics - Global forecast to 2024".
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us